MEMBRANE FLUIDITY MEMBRANE LIPID PATTERN AND CYTOSOLIC CA2-II DIABETIC-PATIENTS WITH MACROVASCULAR COMPLICATIONS( CONTENT IN PLATELETS FROMA GROUP OF TYPE)

Citation
G. Caimi et al., MEMBRANE FLUIDITY MEMBRANE LIPID PATTERN AND CYTOSOLIC CA2-II DIABETIC-PATIENTS WITH MACROVASCULAR COMPLICATIONS( CONTENT IN PLATELETS FROMA GROUP OF TYPE), Diabetes care, 18(1), 1995, pp. 60-63
Citations number
31
Categorie Soggetti
Endocrynology & Metabolism","Medicine, General & Internal
Journal title
ISSN journal
01495992
Volume
18
Issue
1
Year of publication
1995
Pages
60 - 63
Database
ISI
SICI code
0149-5992(1995)18:1<60:MFMLPA>2.0.ZU;2-U
Abstract
OBJECTIVE - To evaluate platelet membrane fluidity and some platelet m etabolic parameters in type II diabetic patients with macrovascular co mplications. RESEARCH DESIGN AND METHODS - In a group of 21 type II di abetic patients with macrovascular complications, we evaluated platele t membrane fluidity [marking intact resting platelets with the fluores cent probe 1,4-(trimethylamino) phenyl-4-phenylhexatriene (TMA-DPH)], platelet membrane lipid pattern (cholesterol:phospholipid [C:PL] ratio and individual phospholipids), and platelet cytosolic Ca2+ content (m arking intact resting platelets with the fluorescent probe Fura 2AM). RESULTS - Platelet membrane fluidity is decreased in type II diabetic patients with macrovascular complications compared with normal subject s (P < 0.001). Platelet membrane C:PL ratio and cytosolic Ca2+ content do not discriminate normal subjects from diabetic patients, and for i ndividual phospholipids, only phosphatidylethanolamine is decreased in diabetic patients compared with control subjects (P = 0.051). In norm al subjects, the polarization degree of TMA-DPH is related to phosphat idylserine (P < 0.05) and phosphatidylcholine (P < 0.05), and in diabe tic patients the polarization degree of TMA-DPH is related to C:PL rat io (P < 0.05) and sphyngomyelin (P < 0.05). CONCLUSIONS - In type II d iabetic patients with macrovascular complications, we observed an abno rmality of platelet membrane fluidity, which may contribute to platele t functional alteration present in this clinical condition.